GLP-3 RT (also known by its research designation LY3437943) is a 39-amino-acid synthetic peptide engineered as a triple agonist of the GIP, GLP-1, and glucagon receptors.
The combined receptor agonism is being studied for its effects on glycemic regulation, satiety signaling, and energy expenditure in metabolic research models.
Reconstitution protocols typically use 1–2ml of bacteriostatic water per 10mg vial, with titrated weekly research dosing. See the product detail page for the recommended laboratory dosing schedule.
This summary is provided for research and laboratory professionals only.